{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:51:36Z","timestamp":1772790696934,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/fpc.0000000000000035","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T09:09:45Z","timestamp":1392628185000},"page":"204-210","source":"Crossref","is-referenced-by-count":36,"title":["The effects of CES1A2 A(\u2212816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Cheng","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfu","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/FPC.0b013e3283385420","article-title":"Clopidogrel pathway.","volume":"20","author":"Sangkuhl","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/gtmb.2011.0010","article-title":"Mutation-sensitive molecular switch method to detect CES1A2 mutation in the Chinese Han and Yao populations.","volume":"15","author":"Ding","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.","volume":"344","author":"Zhu","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-3-20210213","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/dmd.108.024943","article-title":"Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants.","volume":"37","author":"Zhu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bcp.2008.12.017","article-title":"Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.","volume":"77","author":"Zhu","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"d4588","DOI":"10.1136\/bmj.d4588","article-title":"Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.","volume":"343","author":"Bauer","year":"2011","journal-title":"BMJ"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1538-7836.2012.04756.x","article-title":"Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.","volume":"10","author":"Reny","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/tx2004085","article-title":"Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.","volume":"25","author":"Dansette","year":"2012","journal-title":"Chem Res Toxicol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:53Z","timestamp":1620951713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201404000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000035","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}